FDA Notices of Judgment Collection, 1908-1966

19661. Adulteration and misbranding of magnesium sulphate compound capsules, silver nitrate compound capsules, decaphen capsules, benzoic acid compound tablets, ammonium salicylate compound tablets, and cinchophen tablets. U. S. v. S. F. Durst & Co. Pleas of guilty. Fines, $300.